THE MEDICINES PATENT POOL IMPROVES ACCESS TO AFFORDABLE AND APPROPRIATE HIV, HEPATITIS C AND TUBERCULOSIS MEDICINES IN LOW- AND MIDDLE-INCOME COUNTRIES.

scroll down to find out how

IT DOES THIS BY ADDRESSING A KEY CHALLENGE IN EQUITABLE ACCESS TO TREATMENT – THE NEED FOR MULTIPLE SOURCES OF AFFORDABLE, QUALITY ASSURED MEDICINES FOR USE IN DEVELOPING COUNTRIES.

SHARING TECHNOLOGY AND PATENTS IS KEY

number of products licensed to the organisation

017

PATENTS REWARD INNOVATION AND IF LICENSED WIDELY, THEY CAN SPUR THE DEVELOPMENT OF A COMPETITIVE MARKET AND FURTHER INNOVATION TO MEET SPECIFIC DEVELOPING COUNTRY NEEDS.

The MPP partners with stakeholders through a voluntary licensing and patent pooling model.

Placeholder image

Disease Experts

Placeholder image

Civil Society

Placeholder image

Patient Groups

help MPP identify treatment needs

The World Health Organization works with the MPP to prioritise medicines and forecast future uptake Patent holders agree to license their medicines to the MPP

THE MPP LICENSES RIGHTS TO MANUFACTURE THESE TREATMENTS TO GENERIC PHARMACEUTICAL COMPANIES

A Placeholder image
A Placeholder image
A Placeholder image
A Placeholder image
A Placeholder image

LICENSING TERMS ENCOURAGE THE SALE OF LOW-COST VERSIONS IN MORE THAN A HUNDRED DEVELOPING COUNTRIES

LICENSING TERMS

MANUFACTURES CAN ALSO COMBINE DIFFERENT MEDICINES TO PRODUCE FIXED-DOSE COMBINATIONS

...two or three treatments in one pill

...and special formulations for children.

NEW TREATMENTS BECOME AVAILABLE FASTER IN DEVELOPING COUNTRIES

GENERIC COMPETITION BRINGS PRICES DOWN

and more people gain access to the medicines they need.

THE MEDICINES PATENT POOL IMPROVES ACCESS TO AFFORDABLE AND APPROPRIATE HIV, HEPATITIS C AND TUBERCULOSIS MEDICINES IN LOW- AND MIDDLE-INCOME COUNTRIES.

IT DOES THIS BY ADDRESSING A KEY CHALLENGE IN EQUITABLE ACCESS TO TREATMENT – THE NEED FOR MULTIPLE SOURCES OF AFFORDABLE, QUALITY ASSURED MEDICINES FOR USE IN DEVELOPING COUNTRIES.

SHARING TECHNOLOGY AND PATENTS IS KEY

number of medicines licensed to the organisation

017

PATENTS REWARD INNOVATION AND IF LICENSED WIDELY, THEY CAN SPUR THE DEVELOPMENT OF A COMPETITIVE MARKET AND FURTHER INNOVATION TO MEET SPECIFIC DEVELOPING COUNTRY NEEDS.

The MPP partners with stakeholders through a voluntary licensing and patent pooling model.

VIEW OUR STAKEHOLDERS
Placeholder image

Disease Experts

Placeholder image

Civil Society

Placeholder image

Patient Groups

help MPP identify treatment needs

The World Health Organization works with the MPP to prioritise medicines and forecast future uptake

Patent holders agree to license their medicines to the MPP

THE MPP LICENSES RIGHTS TO MANUFACTURE THESE TREATMENTS TO GENERIC PHARMACEUTICAL COMPANIES

A Placeholder image

LICENSING TERMS ENCOURAGE THE SALE OF LOW-COST VERSIONS IN MORE THAN A HUNDRED DEVELOPING COUNTRIES

LICENSING TERMS

MANUFACTURES CAN ALSO COMBINE DIFFERENT MEDICINES TO PRODUCE FIXED-DOSE COMBINATIONS

...two or three treatments in one pill

...and special formulations for children.

NEW TREATMENTS BECOME AVAILABLE FASTER IN DEVELOPING COUNTRIES